This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beechman Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Ambrish Vyas: Innovator in Thiazoloindolinone Compounds
Introduction
Ambrish Vyas is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address the side effects of chemotherapy and radiation therapy.
Latest Patents
Ambrish Vyas holds a patent for Thiazoloindolinone compounds. This patent focuses on Thiazole-indole compounds that serve as cyclin-dependent kinase 11 inhibitors. These compounds are designed to prevent or reduce the severity of epithelial cytotoxicity side effects, such as alopecia, plantar-palmar syndrome, and mucositis, which can occur in patients undergoing chemotherapy and/or radiation therapy.
Career Highlights
Ambrish Vyas is currently employed at Smithkline Beecham Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in medicinal chemistry has positioned him as a valuable asset in the development of new therapeutic agents.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Ambrish Vyas is a dedicated inventor whose work in Thiazoloindolinone compounds has the potential to significantly improve the quality of life for patients undergoing cancer treatments. His contributions to the field of medicinal chemistry are commendable and reflect his commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile